Follow ProQR Therapeutics N.V.. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.
5 Stories in coverage 0 Programs 0 Registered trials 6-K Nov 12 Latest SEC filing Nov 12 Latest story
Timeline 5 Pipeline 0 Trials 0
All5 Trials and readouts1 Filings and people4
Details
Headquarters Leiden Incorporated Netherlands Industry Pharmaceutical Preparations Formerly ProQR Therapeutics B.V. (to 2014) Also known as ProQR Therapeutics B.V., PRQR How the company describes itself ProQR Therapeutics develops RNA therapies using its Axiomer platform technology, which leverages ADAR-mediated editing to correct single nucleotide mutations in RNA. The clinical-stage company, based in the Netherlands, targets rare and prevalent diseases. source